Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive Induction Chemotherapy With or Without Methotrexate Followed by Consolidation With Stem Cell Rescue in Young Children With Newly Diagnosed Supratentorial PNET and High Risk Medulloblastoma
NCT00336024Phase 3Completed
- Sponsor
- Children's Oncology Group
- Start
- Oct 2007
- Primary completion
- Dec 2016
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
A Phase 3 trial of methotrexate in supratentorial primitive neuroectodermal tumor (sPNET), medulloblastoma, sponsored by Children's Oncology Group. Started Oct 2007; status: completed.
02
Drugs
methotrexate
03
Conditions
supratentorial primitive neuroectodermal tumor (sPNET)medulloblastoma
Beyond the preview
Go deeper on NCT00336024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00336024.